Figure 4 | Scientific Reports

Figure 4

From: Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia

Figure 4

Prognostic value and biomarker potential of PTPN2. (a) Effect of PTPN2 on cancer prognosis. (b) Correlation between PTPN2 expression and overall survival in the TCGA and TARGET cohort. (c) A Comparison of PTPN2 expression before and after ICB treatments across different tumor models in vivo. (d) Ability of PTPN2 to predict response outcome and overall survival in immunotherapy cohorts. (e) The top 12 drugs positively correlated with PTPN2 expression in the CellMiner database.

Back to article page